These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

425 related items for PubMed ID: 26352581

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatocellular carcinoma: current questions and future directions.
    Gish RG.
    Clin Adv Hematol Oncol; 2015 Mar; 13(3):176-9. PubMed ID: 26352425
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib.
    Louandre C, Ezzoukhry Z, Godin C, Barbare JC, Mazière JC, Chauffert B, Galmiche A.
    Int J Cancer; 2013 Oct 01; 133(7):1732-42. PubMed ID: 23505071
    [Abstract] [Full Text] [Related]

  • 14. Treatment of advanced hepatocellular carcinoma: beyond sorafenib.
    Meyer T.
    Lancet Gastroenterol Hepatol; 2018 Apr 01; 3(4):218-220. PubMed ID: 29533189
    [No Abstract] [Full Text] [Related]

  • 15. Complete Response to the Combination of Pembrolizumab and Sorafenib for Metastatic Hepatocellular Carcinoma: A Case Report.
    Chen SC, Chao Y, Yang MH.
    Am J Gastroenterol; 2017 Apr 01; 112(4):659-660. PubMed ID: 28381841
    [No Abstract] [Full Text] [Related]

  • 16. Sorafenib: from literature to clinical practice.
    Di Marco V, De Vita F, Koskinas J, Semela D, Toniutto P, Verslype C.
    Ann Oncol; 2013 Apr 01; 24 Suppl 2():ii30-7. PubMed ID: 23715941
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Regorafenib as treatment for patients with advanced hepatocellular cancer.
    Thillai K, Srikandarajah K, Ross P.
    Future Oncol; 2017 Oct 01; 13(25):2223-2232. PubMed ID: 28766967
    [Abstract] [Full Text] [Related]

  • 19. Refining sorafenib therapy: lessons from clinical practice.
    Bolondi L, Craxi A, Trevisani F, Daniele B, Di Costanzo GG, Fagiuoli S, Cammà C, Bruzzi P, Danesi R, Spandonaro F, Boni C, Santoro A, Colombo M.
    Future Oncol; 2015 Oct 01; 11(3):449-65. PubMed ID: 25360997
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.